PHARMACEUTICAL COMPOSITION HAVING IMMEDIATE RELEASE AND CONTROLLED RELEASE PROPERTIES AND COMPRISING D-THREO-METHYLPHENIDATE

PURPOSE: A pharmaceutical composition is provided to minimize side effects and to show excellent immediate release and controlled release properties, thereby quickly showing drug efficacy with excellent drug compliance and convenience. CONSTITUTION: A pharmaceutical composition comprises immediate r...

Full description

Saved in:
Bibliographic Details
Main Authors AN, TAE KUN, AN, GUG HWAN, KANG, SEUNG RAE, KIM, JONG MIN, CHOI, JU HUEN, SUH, HEA RAN, OH, SEUNG YOUN, SONG, YI SEUL, SEO, SANG KYO, PARK, MI SUN
Format Patent
LanguageEnglish
Korean
Published 27.09.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PURPOSE: A pharmaceutical composition is provided to minimize side effects and to show excellent immediate release and controlled release properties, thereby quickly showing drug efficacy with excellent drug compliance and convenience. CONSTITUTION: A pharmaceutical composition comprises immediate release particles and controlled release particles. The immediate release particles contain: a core layer containing D-threo-methylphenidate; and a taste masking layer selected among hydroxypropyl methylcellulose acetate succinate (HPMCAS), dimethylaminoethyl methacrylate-butyl methacrylate-methyl methacrylate copolymers, and a mixture thereof. The controlled release particles comprises: the core layer; and a release-controlled layer selected among methacrylate-ethyl acrylate copolymers, ethyl acrylate-methyl methacrylate copolymers, and a mixture thereof.
Bibliography:Application Number: KR20120134883